EnteroBiotix CEO featured on The Pharma Letter podcast talking about mastering the microbiome

EnteroBiotix in the news
Written By James McIlroy
Portrait of EnteroBiotix CEO James McIlroy

EnteroBiotix CEO James McIlroy appears on episode 12 of the Pharma Letter Podcast discussing how the company is mastering the microbiome

Our Founder & CEO Dr James McIlroy was recently featured on The Pharma Letter podcast with Simon Wentworth discussing mastering the microbiome.

James discusses how EnteroBiotix is developing its pipeline of highly diverse microbiome enhancing therapeutics through a unique approach to development and manufacturing, focussed on supply chain control and novel technologies.

Listen here to learn more about the future of modern medicine and the massive therapeutic potential of the gut microbiome.

James McIlroy
Previous

EnteroBiotix’s CEO Dr James McIlroy will be presenting at BioTrinity, London 2022
Next

EnteroBiotix will be attending the Jefferies London Healthcare Conference 2021